Agfa HealthCare - Third Quarter 2012

Agfa HealthCareSupported by positive currency effects, Agfa HealthCare's revenue increased by 11.2 percent to 297 million Euro. The digital radiography business (consisting of Computed Radiography and Direct Radiography) performed well, adding to the continued growth of the IT segment. Compared to the very weak third quarter of 2011, film volumes also increased.

IT performed strongly in Germany and the North of Europe, as well as in Latin America. Business in the South of Europe continued to suffer from the recession. In the USA, the imaging IT business was somewhat soft.

Thanks to Agfa HealthCare's film price increases and the measures to support profitability, the gross profit margin improved from 32.2 percent in the third quarter of last year to 35.0 percent. Recurring EBITDA reached 27.9 million Euro (or 9.4 percent of revenue). Recurring EBIT improved to 17.1 million Euro (or 5.8 percent of revenue).

In the field of Imaging, Agfa HealthCare's CR 10-X table-top computed radiography (CR) system received FDA approval. The system is now available throughout North America. The CR 10-X system offers small hospitals and practices an affordable way to upgrade from analog to high-quality digital imaging. Also in the third quarter, Agfa HealthCare signed a new three-year multi-source contract with the group purchasing division of the Premier healthcare alliance for its entire portfolio of direct radiography (DR) products. Premier counts over 2,600 member hospitals in the USA.

Furthermore, the Radiologischen Gemeinschaftspraxis Betzdorf became the first healthcare center in Germany to put Agfa HealthCare's DX-D 800 system into service. This complete DR solution is suitable for both static and dynamic imaging.

In Imaging IT, Agfa HealthCare introduced its new Global Remote Incident Prevention (GRIP) services. As part of the GRIP services, a centralized global monitoring center and technical team continually monitor the IMPAX PACS solutions (as well as certain third-party systems) of customers worldwide to identify and prevent possible incidents before they occur. In a later stage, other Agfa HealthCare solutions will also be covered.

Agfa HealthCare also launched a new version of its IMPAX Data Center. The IMPAX Data Center 3.0 enables hospitals and hospital groups to consolidate all imaging data into a single, centralized repository.

In the UK, Agfa HealthCare signed a seven-year contract extension with Shrewsbury and Telford Hospital NHS Trust. The contract includes a full upgrade of their PACS systems and the replacement of eight CR units. The trust will also trial two of Agfa HealthCare's DX-D 100 mobile DR systems.

Agfa HealthCare further strengthened its leading position for Enterprise IT in the German speaking countries of Europe. The St. Josefskrankenhaus in Heidelberg (Germany), for instance, signed a contract for the replacement of its existing Hospital Information System (HIS) by Agfa HealthCare's ORBIS solution.

In September, Agfa HealthCare announced a global strategic relationship with Orion Health, a global leader in health information exchange and healthcare integration solutions. Thanks to the partnership, Agfa HealthCare will be able to extend the reach of both its ICIS solution (Imaging Clinical Information Services), and its ORBIS Enterprise IT platform. Orion Health will include Agfa HealthCare's ICIS solution (including the IMPAX Data Center and the XERO image viewer) in its offering.

About Agfa
The Agfa-Gevaert Group is one of the world's leading companies in imaging and information technology. Agfa develops manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), for the healthcare sector (Agfa HealthCare), and for specific industrial applications (Agfa Materials). Agfa is headquartered in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries around the globe. The Agfa-Gevaert Group achieved a turnover of 2,948 million euro in 2010.

About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading global provider of diagnostic imaging and healthcare IT solutions. The company has nearly a century of healthcare experience and has been a pioneer on the healthcare IT market since the early 1990's. Today Agfa HealthCare designs, develops and delivers state-of-the-art systems for capturing, managing and processing diagnostic images and clinical/administrative information for hospitals and healthcare facilities, as well as contrast media solutions to enable effective medical imaging results. The company has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2010 were 1,180 million euro.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...